If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMirriad Advertising Regulatory News (MIRI)

Share Price Information for Mirriad Advertising (MIRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.25
Ask: 1.35
Change: 0.00 (0.00%)
Spread: 0.10 (8.00%)
Open: 1.33
High: 1.33
Low: 1.30
Prev. Close: 1.30
MIRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

13 Apr 2023 08:21

RNS Number : 1066W
Panmure Gordon (UK) Limited
13 April 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Gordon (UK) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mirriad Advertising PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Mirriad Advertising PLC

(d) Date dealing undertaken:

12 Apr 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p Ordinary

Purchase

 

114,229

0.01815

 

0.0175

 

10p Ordinary

Sales

0

0

 

0

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

13/04/2023

Contact name:

Mohammed Jamal

Telephone number:

020 7886 2780

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERZZGMDNFGGFZG
Date   Source Headline
15th Jun 202111:00 amRNSMirriad CEO to present at OTCQX Conference
14th Jun 20213:51 pmRNSApproval of resolutions at AGM
2nd Jun 202112:00 pmRNSMirriad CEO to present at LD Micro Invitational XI
28th May 20213:51 pmRNSHolding(s) in Company
21st May 20217:00 amRNSAnnual Report and Accounts and Notice of AGM
20th May 20217:00 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSMirriad reveals latest effectiveness research
12th May 202111:05 amRNSSecond Price Monitoring Extn
12th May 202111:00 amRNSPrice Monitoring Extension
12th May 20217:00 amRNSResults for the year ended 31 December 2020
10th May 20217:00 amRNSNew agreement with leading food & beverage company
6th May 20217:00 amRNSAppointment of Chief Revenue Officer
21st Apr 202111:05 amRNSSecond Price Monitoring Extn
21st Apr 202111:00 amRNSPrice Monitoring Extension
21st Apr 20217:00 amRNSMirriad upgrades to New York OTCQX® Best Market
15th Apr 20217:00 amRNSNotice of analyst and investor webinar
24th Feb 20211:51 pmRNSBoard Appointment
2nd Feb 202112:14 pmRNSAppointment of Chief Technology Officer
6th Jan 202111:34 amRNSHolding(s) in Company
22nd Dec 20206:02 pmRNSPDMR Dealings Correction
22nd Dec 20205:12 pmRNSPDMR Dealings
15th Dec 20202:56 pmRNSResult of General Meeting and Open Offer
27th Nov 20206:10 pmRNSPosting of Circular
27th Nov 20202:05 pmRNSSecond Price Monitoring Extn
27th Nov 20202:00 pmRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSResults of Accelerated Bookbuild
26th Nov 20204:35 pmRNSProposed Conditional Placing and Open Offer
9th Nov 20207:00 amRNSMirriad launches music alliance
28th Oct 20207:00 amRNSMirriad Signs Contract With Tier One Media Giant
30th Sep 202010:28 amRNSHolding(s) in Company
29th Sep 20201:36 pmRNSHolding(s) in Company
28th Sep 20204:25 pmRNSIssue of Equity
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:02 amRNSSecond Price Monitoring Extn
22nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension
14th Sep 20202:05 pmRNSSecond Price Monitoring Extn
14th Sep 20202:00 pmRNSPrice Monitoring Extension
10th Sep 20207:00 amRNSInterim results
9th Sep 20207:00 amRNSOTC listing
26th Aug 20207:00 amRNSNotice of interim results and webinar
12th Aug 20204:41 pmRNSSecond Price Monitoring Extn
12th Aug 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSApproval of resolutions at AGM
10th Jun 20204:41 pmRNSSecond Price Monitoring Extn
10th Jun 20204:36 pmRNSPrice Monitoring Extension
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:36 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSAnnual Report and Accounts and Notice of AGM
18th May 20202:34 pmRNSExecutive LTIP award, Director and PDMR dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.